You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,667,344


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,667,344
Title: Bronchodilating compositions and methods
Abstract:Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.
Inventor(s): Banerjee; Partha S. (Davis, CA), Pham; Stephen (Sacramento, CA), Akapo; Samuel O. (Vacaville, CA), Chaudry; Imtiaz A. (Napa, CA)
Assignee: Dey, L.P. (Napa, CA)
Application Number:09/887,281
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,667,344
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,667,344: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 6,667,344, providing a detailed analysis of its claims, the patent landscape, and the implications of such a patent.

Background of the Patent

United States Patent 6,667,344, part of the first family of Dey patents, was issued to Dey, L.P. (now part of Mylan Specialty L.P.). This patent is associated with formulations and methods related to pharmaceuticals, specifically focusing on the stability of formulations during long-term storage[4].

Claims of the Patent

The claims of a patent define the scope of the invention and what is protected under the patent. For U.S. Patent 6,667,344, the claims typically include:

  • Composition Claims: These define the specific formulations and their components.
  • Method Claims: These outline the processes and methods used to prepare and stabilize the formulations.
  • Use Claims: These specify the intended uses of the formulations.

Composition Claims

The composition claims in this patent would detail the exact chemical and physical properties of the formulations, including the active ingredients, excipients, and any other components that contribute to the stability and efficacy of the product.

Method Claims

Method claims would cover the procedures for preparing, storing, and handling the formulations to ensure their stability over time. This includes any specific steps, conditions, or equipment required.

Use Claims

Use claims would specify the therapeutic or other uses for which the formulations are intended. This could include treatment of specific diseases or conditions.

Patent Landscape Analysis

To understand the position of U.S. Patent 6,667,344 within the broader patent landscape, a comprehensive patent landscape analysis is necessary.

Defining Scope and Keywords

The first step involves defining the technology field and specific keywords related to the patent. For pharmaceutical formulations, keywords might include "pharmaceutical stability," "long-term storage," and "formulation methods"[3].

Searching and Organizing Patents

Using databases such as the USPTO's Public Search Facility or the Global Dossier service, one can search for relevant patents based on these keywords. Organizing these patents by factors like filing date, assignee, and classification helps in visualizing the landscape[1][3].

Identifying Trends and Key Players

Analyzing the organized data reveals trends in patent filings and identifies key players in the field. This could include other pharmaceutical companies or research institutions that have filed similar patents.

Analyzing Citations and Evolution

Studying how patents reference each other provides insights into the impact and development of the technology. This helps in understanding the evolutionary path of the formulations and their significance within the industry[3].

Key Insights from Patent Landscape Analysis

A patent landscape analysis offers several critical insights:

  • Technological Trends: It reveals ongoing innovations and predicts future trends in pharmaceutical formulations.
  • Key Players: It identifies significant contributors and competitors in the field.
  • Patent Strength: It assesses the strength of the patent portfolio and potential vulnerabilities.
  • Strategic Decisions: It provides actionable insights for strategic decisions regarding the invention or patented innovation[3].

Legal Considerations

Public Use and Confidentiality

The validity of a patent can be challenged if the invention was in public use more than one year prior to the patent application date. The case of Dey, L.P. v. Sunovion Pharmaceuticals, Inc. highlights the importance of maintaining confidentiality. If a third party uses the invention without confidentiality, it can invalidate the patent claims[4].

Small Claims Patent Court

The concept of a small claims patent court, currently under study by the Administrative Conference of the United States (ACUS), could impact how patent disputes related to such formulations are handled. This court would aim to provide a more streamlined and cost-effective way to resolve patent disputes, which could be particularly relevant for smaller entities or individual inventors[5].

Practical Implications

Understanding the scope and claims of U.S. Patent 6,667,344 has several practical implications:

  • Innovation and R&D: It guides researchers and developers in avoiding infringement and creating new, non-infringing formulations.
  • Business Strategy: It helps businesses in making informed decisions about licensing, collaboration, or litigation.
  • Competitive Advantage: It provides insights into the competitive landscape, enabling companies to position themselves strategically within the market.

Case Study: Dey, L.P. v. Sunovion Pharmaceuticals, Inc.

The case of Dey, L.P. v. Sunovion Pharmaceuticals, Inc. is a significant example of how the scope and claims of a patent can be challenged. Sunovion's clinical trials of a formulation similar to Dey's were deemed a public use, invalidating Dey's patent claims due to lack of confidentiality. This case underscores the importance of maintaining secrecy during the development and testing phases[4].

Key Takeaways

  • Detailed Claims Analysis: Understanding the composition, method, and use claims of a patent is essential for navigating intellectual property rights.
  • Patent Landscape: Conducting a thorough patent landscape analysis helps in identifying trends, key players, and potential vulnerabilities.
  • Legal Considerations: Maintaining confidentiality and avoiding public use are critical for the validity of a patent.
  • Strategic Insights: Patent analysis provides actionable insights for strategic business and R&D decisions.

FAQs

What is the primary focus of U.S. Patent 6,667,344?

The primary focus of U.S. Patent 6,667,344 is on the stability of pharmaceutical formulations during long-term storage.

How does a patent landscape analysis help in understanding a patent?

A patent landscape analysis helps by identifying trends, key players, and the evolutionary path of the technology, providing insights into the competitive landscape and potential vulnerabilities.

What is the significance of maintaining confidentiality in patent development?

Maintaining confidentiality is crucial to avoid public use, which can invalidate patent claims if the invention is used without secrecy more than one year prior to the patent application date.

What is the proposed small claims patent court, and how might it impact patent disputes?

The proposed small claims patent court aims to provide a more streamlined and cost-effective way to resolve patent disputes, particularly beneficial for smaller entities or individual inventors.

How can businesses use patent landscape analysis for strategic decisions?

Businesses can use patent landscape analysis to make informed decisions about licensing, collaboration, or litigation, and to position themselves strategically within the market.

Sources

  1. USPTO - Search for patents. (2018, October 18). Retrieved from https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov. Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. How to Do Patent Landscape Analysis. Goldstein Patent Law. Retrieved from https://www.goldsteinpatentlaw.com/how-to-patent-landscape-analysis/
  4. United States Court of Appeals for the Federal Circuit. (2013, May 16). Retrieved from https://cafc.uscourts.gov/opinions-orders/12-1428.opinion.5-16-2013.1.pdf
  5. U.S. Patent Small Claims Court. Administrative Conference of the United States. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,667,344

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,667,344

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2002244211 ⤷  Subscribe
Canada 2438544 ⤷  Subscribe
European Patent Office 1381346 ⤷  Subscribe
Spain 2554476 ⤷  Subscribe
Japan 2004532217 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.